Patents by Inventor Scott Rowlands

Scott Rowlands has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200042748
    Abstract: Techniques for processing I/O operations may include performing DMA (direct memory access) operations between a data storage system, one or more physical storage devices, and a hardware component that communicate over at least one bus using a DMA-based protocol, such as NVMe (Non-Volatile Memory Express). The hardware device may perform encryption and decryption processing of data that is, respectively, stored to, and read from, physical non-volatile storage. The hardware device may optionally perform other processing for other data-related operations such as any of data validation and integrity checking, data deduplication, data compression, and data decompression. When performing DMA transfers, multiple descriptors, such as SGLs (scatter gather lists) or PRPs (physical region pages), for multiple data portions having logically contiguous consecutive logical addresses may be combined into a single descriptor sent in a single DMA operation.
    Type: Application
    Filed: July 31, 2018
    Publication date: February 6, 2020
    Applicant: EMC IP Holding Company LLC
    Inventors: Stephen Richard Ives, Ningdong Li, Seema G. Pai, Daniel J. Rodrigues, Scott Rowlands
  • Publication number: 20190285784
    Abstract: A sensor window may include a substrate and a set of layers disposed onto the substrate. The set of layers may include a first subset of layers of a first refractive index and a second set of layers of a second refractive index different from the first refractive index. The set of layers may be associated with a threshold transmissivity in a sensing spectral range. The set of layers may be configured to a particular color in a visible spectral range and may be associated with a threshold opacity in the visible spectral range.
    Type: Application
    Filed: August 14, 2018
    Publication date: September 19, 2019
    Inventors: Georg J. OCKENFUSS, Scott Rowlands, Markus Bilger
  • Publication number: 20190285785
    Abstract: A sensor window may include a substrate and a set of layers disposed onto the substrate. The set of layers may include a first subset of layers of a first refractive index and a second set of layers of a second refractive index different from the first refractive index. The set of layers may be associated with a threshold transmissivity in a sensing spectral range. The set of layers may be configured to a particular color in a visible spectral range and may be associated with a threshold opacity in the visible spectral range.
    Type: Application
    Filed: March 5, 2019
    Publication date: September 19, 2019
    Inventors: Georg J. OCKENFUSS, Scott Rowlands, Markus Bilger, Jerry Zieba
  • Publication number: 20180231791
    Abstract: An optical filter may include a substrate. The optical filter may include a set of alternating high refractive index layers and low refractive index layers disposed onto the substrate to polarization beam split incident light. The set of alternating high refractive index layers and low refractive index may layers may be disposed such that a first polarization of the incident light with a spectral range of less than approximately 800 nanometers (nm) is reflected by the optical filter and a second polarization of the incident light with a spectral range of greater than approximately 800 nm is passed through by the optical filter. The high refractive index layers may be hydrogenated silicon (Si:H). The low refractive index layers may be silicon dioxide (SiO2).
    Type: Application
    Filed: February 13, 2017
    Publication date: August 16, 2018
    Inventors: Karen Denise HENDRIX, Scott ROWLANDS
  • Publication number: 20140357369
    Abstract: Embodiments that relate to detecting via an image sensor inputs made by a group of users are provided. For example, one disclosed embodiment provides a method including receiving image information of the play space from a capture device, identifying a body of a user within the play space from the received image information, and identifying a head within the play space from the received image information. The method further includes associating the head with the body of the user, identifying an extremity, and if the extremity meets a predetermined condition relative to one or more of the head and body, then performing an action via the computing device.
    Type: Application
    Filed: June 4, 2013
    Publication date: December 4, 2014
    Inventors: Adam Callens, Michael Scott Seamons, Roger Kurtz, Marie Elizabeth Whallon, Kim McAuliffe, Louise Mary Smith, Henry C. Sterchi, Soren Hannibal Nielsen, Michael Saxs Persson, David McCarthy, Bruce Heather, David Amor, Tim Aidley, Scott Rowlands
  • Patent number: 8110687
    Abstract: The present invention provides novel bicyclic compounds useful as inhibitors of protein kinases. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases.
    Type: Grant
    Filed: December 7, 2006
    Date of Patent: February 7, 2012
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Emily F. Calderwood, Alexandra E. Gould, Paul D. Greenspan, Robyn Scott Rowland, Tricia J. Vos, Matthew J. LaMarche
  • Patent number: 8101604
    Abstract: This invention provides alpha-carboline compounds of formula I: wherein R1, R2, R3, R4, R5, and x are as described in the specification. The compounds are useful for treating inflammatory diseases and cancer.
    Type: Grant
    Filed: August 19, 2010
    Date of Patent: January 24, 2012
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Michael E. Hepperle, Julie Fields Liu, R. Scott Rowland, Dilrukshi Vitharana
  • Patent number: 7912051
    Abstract: Described are techniques for providing a plurality of logical connections over a physical connection. A login frame is transmitted for each of the plurality of logical connections from an initiator port to a target port. The login frame includes a payload comprising a first identifier of a virtual port associated with the initiator port. Upon receiving the login frame, a login acceptance frame is transmitted from the target port to the initiator port and includes a second identifier of a virtual port associated with said target port in the payload. The initiator and target ports are included in hardware components in compliance with a version of a protocol that does not support multiple logical connections over a same physical connection. Each logical connection is established as a result of processing including transmitting a login frame and a login acceptance frame.
    Type: Grant
    Filed: December 19, 2008
    Date of Patent: March 22, 2011
    Assignee: EMC Corporation
    Inventors: Scott Rowlands, Brian Riordan, Arieh Don
  • Publication number: 20100311715
    Abstract: This invention provides alpha-carboline compounds of formula I: wherein R1, R2, R3, R4, R5, and x are as described in the specification. The compounds are useful for treating inflammatory diseases and cancer.
    Type: Application
    Filed: August 19, 2010
    Publication date: December 9, 2010
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Michael E. Hepperle, Julie Fields Liu, R. Scott Rowland, Dilrukshi Vitharana
  • Patent number: 7812018
    Abstract: This invention provides alpha-carboline compounds of formula I: wherein R1, R2, R3, R4, R5, and x are as described in the specification. The compounds are useful for treating inflammatory diseases and cancer.
    Type: Grant
    Filed: February 15, 2007
    Date of Patent: October 12, 2010
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Michael E. Hepperle, Julie Fields Liu, R. Scott Rowland, Dilrukshi Vitharana
  • Publication number: 20100022687
    Abstract: A method for producing a lignocellulosic board product is provided. The method comprises providing lignocellulosic material. Furthermore, an adhesive binder system is provided comprising (a) an adhesive binder resin and (b) an extender and/or filler material comprising particularized bran material. The extender and/or filler material does not have an undesirable effect on the chemical and/or the physical properties of the adhesive binder resin to which the extender and/or filler material is added. It also does not impede the performance of the adhesive binder system during subsequent use in producing the lignocellulosic board product. Substantially no flour balling is present in the extender and/or filler material and in the adhesive binder system, respectively. Then, the lignocellulosic material and the adhesive binder system are combined. Finally, the combined lignocellulosic material and adhesive binder system are formed into the lignocellulosic board product.
    Type: Application
    Filed: July 22, 2009
    Publication date: January 28, 2010
    Applicant: WILLAMETTE VALLEY COMPANY
    Inventors: Wally Rowland, Tim C. Ayers, Robert J. Rubash, Scott Rowland, Philip N. Cote, Randall C. Zenke
  • Patent number: 7045535
    Abstract: Certain cyclic compounds are presented as well as their use for inhibiting paramyxovirus neuraminidase.
    Type: Grant
    Filed: March 8, 2002
    Date of Patent: May 16, 2006
    Assignee: BioCryst Pharmaceuticals, Inc.
    Inventors: Pooran Chand, Yarlagadda S. Babu, R. Scott Rowland, Tsu-Hsing Lin
  • Patent number: 6936719
    Abstract: Compounds of formula (I) are useful as inhibitors of trypsin like serine protease enzymes such as thrombin, factor VIIa, factor Xa, TF/FVIIa, and trypsin. These compounds could be useful to treat and/or prevent clotting disorders, and as anticoagulating agents.
    Type: Grant
    Filed: December 18, 2003
    Date of Patent: August 30, 2005
    Assignee: BioCryst Pharmaceuticals, Inc.
    Inventors: Yarlagadda S. Babu, R. Scott Rowland, Pooran Chand, Pravin L. Kotian, Yahya El-Kattan, Shri Niwas
  • Publication number: 20040162281
    Abstract: Compounds of formula (I) are useful as inhibitors of trypsin like serine protease enzymes such as thrombin, factor VIIa, factor Xa, TF/FVIIa, and trypsin. These compounds could be useful to treat and/or prevent clotting disorders, and as anticoagulating agents.
    Type: Application
    Filed: December 18, 2003
    Publication date: August 19, 2004
    Applicant: BIOCRYST PHARMACEUTICALS, INC.
    Inventors: Yarlagadda S. Babu, R. Scott Rowland, Pooran Chand, Pravin L. Kotian, Yahya El-Kattan, Shri Niwas
  • Publication number: 20040138170
    Abstract: The compounds represented by the formulae (I) wherein X is selected from the group consisting of: O, S, N—R1, and CHR1; Y and Y′ is individually selected from H, OR1, NR1R2, and N3 Z and Z′ is individually selected from II, OR1, and NR1R2 R=II, formula (II), formula (III), or formula (III), R1 and R2 is selected from H, alkyl, acyl, aryl which may be substituted or unsubstituted, R3 is selected from H, alkyl, alkenyl, alkynyl, aryl, acyloxyalkyl, and pivaloyloxyalkyl, B is selected from 5 or 6-substituted uracil or cytosine, pseudouracil, N-substituted pseudouracil, 2-thiouracil, 2-thiocytosine, 5- or 6-substituted 2-thiouracil and 2-thiocytosine, 6-azauracil, 5-azacytosine, 8-azapurines, and 7-aza-8-deazapurines. Substitutions may be halosubstituted alkyl, halosubstituted alkenyl, halosubstituted alkynyl, halosubstituted aryl, alkylthio, or NR1R2.
    Type: Application
    Filed: March 3, 2004
    Publication date: July 15, 2004
    Inventors: John A. Montgomery, Yarlagadda S Babu, Pooran Chand, R Scott Rowland
  • Patent number: 6699994
    Abstract: Compounds of formula (I) are useful as inhibitors of trypsin like serine protease enzymes such as thrombin, factor VIIa, factor Xa, TF/FVIIa, and trypsin. These compounds could be useful to treat and/or prevent clotting disorders, and as anticoagulating agents.
    Type: Grant
    Filed: April 23, 2002
    Date of Patent: March 2, 2004
    Assignee: BioCryst Pharmaceuticals, Inc.
    Inventors: Yarlagadda S. Babu, R. Scott Rowland, Pooran Chand, Pravin L. Kotian, Yahya El-Kattan, Shri Niwas
  • Patent number: 6653340
    Abstract: The present invention is concerned with new compounds, and particularly those having a fused bicyclic ring substituted with an amidine moiety. These compounds are each potent inhibitors of Factor D of the alternate pathway of complement, C1s of the classical pathway of complement, Factors Xa, XIIa, VIIa and thrombin of the coagulation pathway, plasmin in the fibrinolytic pathway, and kallikrein and high molecular weight kininogen in the inflammatory pathways. These proteases, which have serine in their active site, are called serine proteases and they are pivotal to most of the processes of inflammation and coagulation. In fact, these various systems are interactive with one another and it is difficult to activate one pathway without it influencing the others.
    Type: Grant
    Filed: September 27, 2000
    Date of Patent: November 25, 2003
    Assignee: BioCryst Pharmaceuticals, Inc.
    Inventors: Yarlagadda S. Babu, J. Claude Bennett, Shri Niwas, R. Scott Rowland
  • Patent number: 6640528
    Abstract: A tractor mounted boom structure is provided where the boom is adapted, in one mode, to connect a rotary cutter and in a second mode is adapted to connect to a bucket to form a backhoe. The system comprises a mainframe structure adapted to be mounted to a tractor such as by a three-point hitch associated with a tractor. Extending from the frame structure is a first or Primary boom. Connected to the end of the first boom is a second boom. An array of hydraulic cylinders is provided that enables the first boom to articulate with respect to the frame structure and permits the second boom to articulate with respect to the first boom. The second boom is provided with a connector assembly that enables the second boom to be connected to either a rotary cutter or to a bucket. When used to support a rotary cutter, the first boom is generally maintained in a locked position with respect to the mainframe structure of the system.
    Type: Grant
    Filed: January 8, 2002
    Date of Patent: November 4, 2003
    Inventor: Scott Rowland
  • Publication number: 20020081572
    Abstract: Novel paramyxovirus hemagglutinin-neuraminidase active site and methods for enabling the design and selection of inhibitors with that active site are provided. Also provided is machine-readable data storage medium comprising structure coordinates of the novel paramyxovirus hemagglutinin-neuraminidase active site.
    Type: Application
    Filed: July 27, 2001
    Publication date: June 27, 2002
    Inventors: Garry Taylor, Allen Portner, Toru Takimoto, Y. Sidhakar Babu, R. Scott Rowland